Study S000384

The Effect of GLP-1 on Postprandial Glucagon Secretion During Prolonged and Intermittent Stimulation of the GLP-1 Receptor Independent of The Gastric Emptying Rate. A Randomized, Open-label Study in People With Type 1 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT02584582
Acronym: ALFA-1
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 10
Start: 2015-07
Primary completion: 2015-11
Lead sponsor: Hvidovre University Hospital
Conditions: Type 1 Diabetes
Interventions: DRUG:Liraglutide; DRUG:Exenatide; PROCEDURE:Liquid meal test; OTHER:No drug (Baseline day)
Results posted: FALSE

Registered primary outcomes

Glucagon concentration (postprandial) [4 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.